在一次性心脏肉瘤幸存者的生物假体肺功能障碍:临床考虑和治疗选择
Davide Maione1,2, Antonio De Luca1, Andrea Pezzato1,2
1Cardiothoracovascular Department, Division of Cardiology Azienda Sanitaria Universitaria Giuliano-Isontina and University of Trieste Trieste Italy.
这项案例研究表明,在心脏肉瘤的激进手术和化疗后,患者的存活率很高. 密切的患者随访对于管理潜在的早期术后并发症至关重要.
科学领域:
- 心脏病学 心脏病学
- 在瘤学瘤学.
- 手术瘤学手术瘤学
背景情况:
- 心脏瘤是一种罕见且具有攻击性的瘤.
- 早期诊断和综合治疗对于患者的治疗结果至关重要.
更多相关视频
11:20A Rodent Model of The Ross Operation: Syngeneic Pulmonary Artery Graft Implantation in A Systemic Position
Published on: April 1, 2022
05:31Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
相关概念视频
Mitral Valve Prolapse I: Introduction
Mitral Valve Prolapse II: Assessment and Management
Mitral Valve Prolapse III: Nursing Management
Mitral Stenosis III: Medical Management
Mitral Stenosis IV: Nursing Management
Cardiomyopathy V: Interprofessional Care
